Given annually to early-career scientists whose research has the potential to significantly improve the prevention, diagnosis, and treatment of cancer, this year's nine Runyon-Rachleff awards include grants of $400,000 over two years to five early-career scientists. Each of the awardees will have the opportunity to apply for up to two additional years of funding (for a total of $800,000 over four years). The foundation also awarded "Stage 2" support to four previously named Runyon-Rachleff awardees who have demonstrated significant progress on their proposed research during the first two years of the award. This year, the foundation increased the amount awarded annually to $200,000 from $150,000.
In addition, Damon Runyon Fellowships were awarded to eighteen early-career researchers who are working in the laboratories of leading senior investigators. The four-year awards are focused on encouraging innovative, early-career researchers to pursue careers in cancer research by providing them independent funding to work on their projects.
Last but not least, the foundation also named six recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists; the award provides additional funding to scientists completing a Damon Runyon Fellowship Award who have greatly exceeded the foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way cancer is prevented, diagnosed, and treated. Each Frey awardee will receive $100,000 to be used toward their research.